Actively Recruiting
Weaning Approaches for Vasopressin in Sepsis
Led by Hospital Nossa Senhora da Conceicao · Updated on 2026-01-02
82
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study, we aim to evaluate the incidence of hypotension during vasopressin weaning by comparing two methods - titrated reduction versus abrupt withdrawal - through the conduct of a randomized clinical trial.
CONDITIONS
Official Title
Weaning Approaches for Vasopressin in Sepsis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years
- Admitted to the Intensive Care Unit
- Patients with vasopressor dependent sepsis
- Receiving combined norepinephrine and vasopressin therapy
You will not qualify if you...
- Withdrawal or reduction of vasopressin due to a plan of treatment limitation or palliative care
- Withdrawal or reduction of vasopressin associated with starting adrenaline or any other vasopressor
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Nossa Senhora da Conceição
Porto Alegre, Rio Grande do Sul, Brazil, 91350200
Actively Recruiting
Research Team
W
Wagner Luis Nedel, Critical Care Physician, PhD
CONTACT
R
Rafael Barberena Moraes, Critical Care Physician, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here